3,182 hedge funds and large institutions have $196B invested in Pfizer in 2022 Q1 according to their latest regulatory filings, with 156 funds opening new positions, 1,374 increasing their positions, 1,338 reducing their positions, and 183 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding:

12% less capital invested

Capital invested by funds: $222B → $196B (-$25.8B)

15% less first-time investments, than exits

New positions opened: 156 | Existing positions closed: 183

34% less funds holding in top 10

Funds holding in top 10: 249165 (-84)

Holders
3,182
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
165
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.18B
Puts
$3.23B
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
101
$202M
102
$201M
103
$192M
104
$187M
105
$185M
106
$184M
107
$181M
108
$180M
109
$179M
110
$176M
111
$176M
112
$172M
113
$171M
114
$171M
115
$170M
116
$167M
117
$162M
118
$159M
119
$159M
120
$159M
121
$158M
122
$157M
123
$157M
124
$156M
125
$156M